Section Arrow
Quote
NVNO.NASDAQ
- enVVeno Medical Corporation
Quotes are at least 15-min delayed:2026/10/01 14:02 EDT
Regular Hours
Last
 8.14
+0.34 (+4.36%)
Day High 
9.41 
Prev. Close
7.8 
1-M High
11.82 
Volume 
22.48K 
Bid
8.01
Ask
8.34
Day Low
8.09 
Open
8.82 
1-M Low
7.01 
Market Cap 
5.42M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.79 
20-SMA 9.68 
50-SMA 10.32 
52-W High 35.175 
52-W Low 7.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-24.97/-0.45
Enterprise Value
5.73M
Balance Sheet
Book Value Per Share
29.75
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NXLNexalin Technology Inc.7.33+3.05+71.26%-- 
QSIQuantum-Si1.39+0.32+29.91%-- 
PACBPacific Biosciences of California2.445+0.075+3.16%-- 
MDTMedtronic plc85.54-0.75-0.87%21.25PE
VNRXVolitionRX Limited0.2381-0.0199-7.71%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which wasa surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.